FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 52 filers reported holding FUSION PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,670,516 | $11,562 | 3.36% |
ADAMS STREET PARTNERS LLC | 2,947,809 | $9,285,598 | 3.10% |
Pivotal bioVenture Partners Investment Advisor LLC | 1,560,984 | $4,917,100 | 2.14% |
Sio Capital Management, LLC | 260,448 | $820,411 | 0.30% |
BRAIDWELL LP | 2,000,000 | $6,300,000 | 0.21% |
Orbimed Advisors | 3,224,770 | $10,158,026 | 0.19% |
TPG GP A, LLC | 2,551,794 | $8,038,151 | 0.16% |
Artal Group S.A. | 750,000 | $2,363 | 0.13% |
RA Capital Management | 659,992 | $2,078,975 | 0.04% |
SECTORAL ASSET MANAGEMENT INC | 57,297 | $180,486 | 0.04% |